Healthcare -
Biotechnology - NYSE - CH
$ 1.83
4.57 %
$ 177 M
Market Cap
-0.77
P/E
ADCT - INTEREST INCOME & EXPENSE
Interest Income & Expense ADCT - ADC Therapeutics SA
46.3 M
LAST VALUE
58.93%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR